Artificial Intelligence Based Timing, Infarct Size and Outcomes in Acute Coronary Occlusion Myocardial Infarction
Recruiting
Observational Study
Coronary Arterial Disease (CAD)
Acute Coronary Syndrome (ACS) Undergoing Percutaneous Coronary Intervention (PCI)
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Observational
- Participants needed
- 1,500 (estimated)
- Sponsor
- Azienda Ospedaliera di Bolzano · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The present study is practice-driven and merely observational and prospective. In clinical routine, patients who suffer from suspected ACS and do not show ST elevation in the ECG, different timing proposals in the guidelines and logistically driven differences lead to considerably variable timings in invasive coronary anatomy assessments. This handling may lead to larger infarct sizes when OMI is …
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Age \> 18 yrs
* Working diagnosis of Non- ST Elevation Acute Coronary Syndrome after the assessment by specialist
Exclusion Criteria:
* ST-Elevation Myocardial infarction
* Age \< 18 yrs
* Major sustained ventricular arrhythmias
* Corrupted ECG images
* Poor digitalisation q…
Contacts